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Abstract
Background: Dentin sialophosphoprotein (Dspp) is a multidomain, secreted protein that is critical for the
formation of tooth dentin. Mutations in DSPP cause inherited dentin defects categorized as dentin dysplasia type II
and dentinogenesis imperfecta type II and type III. Dentin sialoprotein (Dsp), the N-terminal domain of dentin
sialophosphoprotein (Dspp), is a highly glycosylated proteoglycan, but little is known about the number, character,
and attachment sites of its carbohydrate moieties.
Results: To identify its carbohydrate attachment sites we isolated Dsp from developing porcine molars and
digested it with endoproteinase Glu-C or pronase, fractionated the digestion products, identified fractions
containing glycosylated peptides using a phenol sulfuric acid assay, and characterized the glycopeptides by
N-terminal sequencing, amino acid analyses, or LC/MSMS. To determine the average number of sialic acid
attachments per N-glycosylation, we digested Dsp with glycopeptidase A, labeled the released N-glycosylations
with 2-aminobenzoic acid, and quantified the moles of released glycosylations by comparison to labeled standards
of known concentration. Sialic acid was released by sialidase digestion and quantified by measuring b-NADH
reduction of pyruvic acid, which was generated stoichiometrically from sialic acid by aldolase. To determine its
forms, sialic acid released by sialidase digestion was labeled with 1,2-diamino-4,5-methyleneoxybenzene (DMB) and
compared to a DMB-labeled sialic acid reference panel by RP-HPLC. To determine the composition of Dsp
glycosaminoglycan (GAG) attachments, we digested Dsp with chondroitinase ABC and compared the
chromotagraphic profiles of the released disaccharides to commercial standards. N-glycosylations were identified at
Asn37, Asn77, Asn136, Asn155, Asn161, and Asn176. Dsp averages one sialic acid per N-glycosylation, which is always in
the form of N-acetylneuraminic acid. O-glycosylations were tentatively assigned at Thr200, Thr216 and Thr316. Porcine
Dsp GAG attachments were found at Ser238 and Ser250 and were comprised of chondroitin 6-sulfate and
chondroitin 4-sulfate in a ratio of 7 to 3, respectively.
Conclusions: The distribution of porcine Dsp posttranslational modifications indicate that porcine Dsp has an
N-terminal domain with at least six N-glycosylations and a C-terminal domain with two GAG attachments and at
least two O-glycosylations.
Background
Type I collagen and proteolytic cleavage products of
dentin sialophosphoprotein (Dspp) are the predominant
proteins in tooth dentin. Collagen constitutes about 90%
of the dentin organic matrix [1], while Dspp-derived
proteins make up more than half of the dentin noncolla-
genous proteins [2-5]. Genetic studies have demon-
strated the importance of the genes encoding type I
collagen (COL1A1, 17q21.31-q22; COL1A2, 7q22.1) and
DSPP (4q21.3) for proper human dentin formation.
Inherited dentin defects are classified as dentinogenesis
imperfecta (DGI) types I, II, or III, or dentin dysplasia
(DD) types I and II [6]. DGI type I is osteogenesis
imperfecta with dentinogenesis imperfecta and is caused
by mutations in COL1A1 and COL1A2 [7]. DD type II
and DGI types II and type III are caused by mutations
in DSPP [8-24]. There are other potential candidate
genes for these disorders, but only DSPP mutations have
been found in DD or DGI kindreds [25].
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Dentin sialophosphoprotein (Dspp) is a chimeric
protein that is cleaved by proteases into its component
parts [26], which are considered to be two parts in
rodents and three in pig. The order of the major
domains of Dspp is Dsp-Dgp-Dpp, where Dsp is dentin
sialoprotein, Dgp is dentin glycoprotein, and Dpp is
dentin phosphoprotein. Dspp is expressed predomi-
nantly by odontoblasts [27], but is detected in bone at
trace levels (0.25% of the level in dentin) [28]. Currently,
the human expressed sequence tag database for DSPP
expression (Hs.678914) shows zero DSPP transcripts out
of 71,655 total mRNA transcripts characterized from
bone.
Dspp is a member of the secretory calcium-binding
phosphoprotein (SCPP) genes, which are involved in the
mineralization of bone, dentin, and enamel [29]. The
SCPP family initially arose from a single ancestral gene:
SPARCL1 or secreted protein, acidic, cysteine-rich like 1
gene [30]. The common features of SCPP genes are few:
their second exon encodes a short signal peptide (~15
amino acids in length) plus the first two amino acids of
the secreted protein. The second coding exon generally
encodes a phosphorylation site SXE/S(p) for Golgi
casein kinase [30,31]. All of the introns are type 0, that
is, the introns do not interrupt codons but are all placed
between codon triplets. The SCPPs divide into two
groups based upon their distinctive amino acid composi-
tions. Acidic SCPPs are rich (over 25%) in glutamate,
aspartate, and phosphoserine. Proline and glutamine-
rich SCPPs are more than 20% proline and glutamine.
Dspp belongs to the acidic group, which is also known
as the dentin/bone group or the SIBLINGs, for small
integrin-binding ligand, N-linked glycoproteins [32,33].
The second coding exon for Dspp (exon 3) is unusual
for the SCPP family. In the pig, this exon encodes the
protein segment from Val3 to Gln31. None of the amino
acids encoded by exon 3 are in the appropriate context
for phosphorylation or glycosylation. Skipping exon 3
would not alter the reading frame, but human mutations
that cause the skipping of exon 3 cause dominant nega-
tive effects that result in dentin malformations, possibly
due to failure to recognize or cleave the signal peptide
[20]. All six of the reported intronic mutations in DSPP
that cause inherited dentin defects are at the end of
intron 2 [9,20,24] or beginning of intron 3 [12,14,17,18].
Perhaps exon 3 was acquired by exon capture after the
Dspp ancestral gene duplicated from another SCPP gene
and is not descended from the short prototypical second
coding exon that encodes a serine that gets
phosphorylated.
Exon 4 encodes the bulk of dentin sialoprotein (Dsp),
from Asp32 to Lys368 [34]. Previously we isolated and
characterized a porcine “Dsp only” transcript. This
mRNA transcript terminated at a polyadenylation/
cleavage site in intron 4 [35]. The porcine Dsp cleavage
product (Ile1 to Arg376) of Dspp is a highly glycosylated
proteoglycan that forms covalent dimers [36]. The Dgp
cleavage product (Ser377 to Gly457) of Dspp is encoded
by the 5’ part of exon 5. Dgp, which has so far only
been described in pig, has a single glycosylation (Asn382)
and four phosphoserines (Ser438, Ser440, Ser442, Ser447)
that are in a highly conserved region near its carboxyl-
terminus [37]. Dentin phosphoprotein (Dpp) is the
highly phosphorylated carboxyl-terminal domain of
Dspp, and is encoded by the rest of exon 5. The coding
region of Dpp varies in length among different indivi-
duals without affecting function [20,38]. Astacin pro-
teases, such as Bmp-1 cleave Dpp from Dspp [39-41],
while Mmp-20 separates Dsp and Dgp [42].
Dentin sialoprotein (Dsp) was previously thought to
be only a minor component of dentin, perhaps only 10%
as abundant as dentin phosphoprotein (Dpp) [43,44],
and later thought to be a nonfunctional pro-domain
that was removed by proteases to activate Dpp [45].
Recently, however it has been determined that Dsp and
Dpp are expressed in stoichiometric amounts as the
N-terminal and C-terminal domains of Dspp [26] and
are found in equal molar amounts in dentin [38,46].
Dspp null mice show severe dentin malformations that
resemble those observed in human DGI-III [47]. Trans-
genic expression of the Dsp domain in the Dspp null
background partially, but substantially, restores the den-
tin phenotype [48]. The widening of predentin observed
in the Dspp knockout as well as the reduced volume of
mineralized dentin are recovered, indicating that both
Dsp and Dpp are necessary for normal dentin minerali-
zation. The mechanisms through which Dsp contributes
to dentin formation are unknown. Characterization of
its posttranslational modifications (PTMs) is an impor-
tant step in understanding its function.
Results
Characterization of Dsp carbohydrate attachment sites
We previously showed that porcine Dsp is a proteogly-
can [36] and that porcine dentin extracts contain the
intact Dsp (the N-terminal domain of Dspp), as well as
lower molecular weight (LMW) cleavage products of
Dsp [42]. It was also known that Dsp has glycosylations
rich in sialic acid [34] and that porcine Dsp has eight
potential N-glycosylation sites based upon analysis of its
primary amino acid sequence [35]. To identify attach-
ment sites and to better characterize the glycosamino-
glycan (GAG) and other carbohydrate attachments in
porcine Dsp, we first targeted the small glycosylated
Dsp cleavage products (LMW-Dsp) from the N-terminal
region of Dsp. As none of the dentin extracts are per-
fectly homogeneous with respect to their contents, we
refer to each extract that we characterized using a
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notation that reflects the extraction and fractionation
steps that produced it (see methods). Routine characteri-
zations of these fractions (SDS-PAGE and Western
blots) are provided in additional files online.
Demineralized dentin powder was subjected to a series
of extraction procedures. A flow chart of the extractions
is provided in Figure 1. Simple analyses of the extracts
(SDS-PAGE stained with CBB and stains-all and a Dsp
immunoblot) are shown in Additional file 1. Intact Dsp
proteoglycan and its cleavage products containing GAG
attachments segregated in the acid/NaCl or “AN”
extract, which was further fractionated by size exclusion
chromatography. Dsp degradation products containing
the GAG attachments displayed a stains-all positive
smear migrating between 50- to 100-kDa on SDS-
PAGE, which were collected in the third (ANS1/2-R3)
of five RP-HPLC fractions (Additional file 2). ANS1/2-
R3 was resolved into two final fractions by repeating the
RP-HPLC run. These two fractions (ANS1/2-R3a and
ANS1/2-R3b) were digested with chondroitinase ABC to
degrade their GAG attachments, which converted the
proteoglycan smears on SDS-PAGE into small peptides
(Figure 2A) that contained no disulfide bridges, as their
mobilities were not affected by the presence or absence
of b-mercaptoethanol (Figure 2B). Chondroitinase ABC
digestion converted ANS1/2-R3a into four peptides and
ANS1/2-R3b into two peptides having apparent molecu-
lar weights ranging from 8- to 25-kDa (Figure 2C).
These six peptides were excised and eluted from the gel
(Figure 2D) and then characterized by N-terminal
sequencing and by amino acid analysis (Figure 2E). The
N-terminal sequence and amino acid compositions
allowed the complete amino acid sequences of the six
peptides to be deduced (Figure 2F).
Peptides 1, 2, 3 and 6 contained the putative GAG
attachment site at Ser238 and the amino acid composi-
tions for each of these proteins showed one fewer serine
than expected. N-terminal sequence for peptide 3 gave a
blank cylce for Ser238. The other N-terminal sequences
did not reach Ser238, but the full-length of each peptide
could be inferred from its amino acid composition. A
blank cycle strongly suggests the presence of a posttran-
slational modification, but additional evidence is gener-
ally required to support this conclusion. In addition, the
four peptides containing Ser238 were only 11 or 12
amino acids in length, but migrated at 15-, 17-, 19- and
20-kDa on SDS-PAGE, suggesting they retained variable
lengths of GAG attachment following the chondroitinase
ABC digestion. From these data we can safely conclude
that Ser238 is a GAG attachment site; however, no infor-
mation from this experiment was gained on the other
putative GAG attachment sites on porcine Dsp (at
Ser220 and Ser250) [36]. No conclusions could be made
from the analyses of peptides 4 and 5. A blank cycle
was observed at Thr200, but the amino acid composition
suggested that this position was a threonine, and there-
fore not necessarily modified.
To gain additional information on posttranslational
modifications in the GAG attachment region of Dsp,
fraction ANS1/2-R3 was digested with pronase. Larger
digestion products from the pronase digestion were
recovered by size exclusion chromatography in the first
eluted fraction (ANS1/2R3-Pr1) (Additional file 3).
ANS1/2R3-Pr1 resolved into 26 fractions by RP-HPLC
and each was assayed for the presence of glycosylations
using the phenol-sulfuric acid assay. Glycosylated pep-
tides were detected in eight of the RP-HPLC fractions:
ANS1/2R3Pr1-d, -e, -h through -l, and -p (Additional
file 3). To identify peptides with GAG attachments, the
eight glycosylated fractions were digested with chondroi-
tinase ABC. The peptides were separated from the
digested carbohydrate by ethanol precipitation and each
supernatant (containing the liberated GAG chains) was
analyzed by phenol sulfuric acid assay. Fractions positive
for glycan attachments (-d, -h, -i, -j, and -p) were
rechromatographed using the same C-18 column that
was used prior to the chondroitinase ABC digestion.
Rechromatographed fractions showing a shift in
their retention times relative to same sample prior to
chondroitinase ABC digestion were characterized by
Dentin Power (40 g) 
50 mM Tris/4 M Guanidine (pH 7.4)
Sup Ppt
(G1P)
Sup Ppt
(G1)
Dialysis
Sup Ppt
Decalcification 0.5 M acetic acid
Sup Ppt
0.5 M acetic acid
(A)
SupPpt
0.5 M acetic acid/2 M NaCl 
(AN)
Sup Ppt
50 mM Tris-HCl/2 M NaCl (pH 7.4)
(TN)
Sup Ppt
50 mM Tris/4 M Guanidine (pH 7.4)
(G2P)
(RIM)
Sup Ppt(G2)
Dialysis against water
Figure 1 Dentin power extraction diagram. The extracts, in bold,
are the first guanidine extract (G1), first guanidine pellet (G1P), acid
(A), acid salt (AN), Tris salt (TN), residual insoluble material (RIM),
second guanidine extract (G2), and the second guanidine pellet
(G2P). Selected extractions were fractionated to isolate Dspp
cleavage products. The AN extract was fractionated by size
exclusion (S) and RP-HPLC (R) to yield HMW Dsp in fractions ANS1/
2-R3, ANS1/2-R4, and ANS1/2-R5. The A extract was fractionated by
size exclusion and RP-HPLC to yield LMW Dsp (AS2R-g).
Chondroitinase activity was detected in the second ion exchange
(Q) fraction of the G2 extact (G2Q2).
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N-terminal sequencing (Figure 3). One peptide (ANS1/
2R3Pr1p-P2) gave a blank cycle for Ser238, while three
peptides (ANS1/2R3Pr1d-D, ANS1/2R3Pr1h-H, and
ANS1/2R3Pr1j-J1) gave blank cycles for Ser250. These
data demonstrate that Ser238 and Ser250 are the GAG
attachment sites for porcine Dsp. The N-terminal
sequences of the peptides in fractions ANS1/2R3Pr1-k
and ANS1/2R3Pr1-l, which were negative for GAG
chains based upon the phenol sulfuric acid assay, were
211EETGVxSGGSGA and 311TDGDNxSK, respectively.
The blank cycles for Thr216 and Thr316 suggest these
residues are modified, but these sequences also show
that Ser220 and Asn315 (which did not give blank cycles)
are not modified, despite their being in appropriate con-
texts for GAG or N-glycosylation attachments,
respectively.
Having established that Ser238 and Ser250, but not
Ser220, have GAG attachments, we then characterized
the nature of the disaccharide attachments at these two
GAG attachment sites. Peptides ANS1/2R3Pr1d-D (with
the GAG attached at Ser250) and ANS1/2R3Pr1p-P2
(with the GAG attached at Ser238) were digested by
chondroitinase ABC. The released carbohydrates were
obtained from the supernatant following ethanol preci-
pitation of the peptide, and were characterized by their
retention times relative to those of disaccharide stan-
dards on NP-HPLC (Figure 4). This determined that
both GAG attachment sites contained chondroitin-6-
sulfate (C6S) and chondroitin-4-sulfate (C4S), and inte-
gration of the areas under their chromatogram peaks
determined that C6 S and C4 S are present in a ratio 7
to 3, respectively.
Characterization of R4 Pronase Digestion Products
Previously we showed that intact Dsp (Dspp-derived
protein that lacks the Dgp and Dpp regions) is in frac-
tion ANS1/2-R4 [42]. This R4 fraction (5 mg) was
digested with pronase, and glycosylated peptides were
collected in the first peak by size exclusion chromato-
graphy (Figure 5A). These peptides resolved into eight
36
16
6
3a 3b
1
2
3
4
5
6
C
250
98
50
6
22
36
148
64
3b3aB
1: 230LDNSDGSPSGNGA (~20-kDa)
2: 230LDNSDGSPSGNGA (~17-kDa)
3: 232NSDGSPxGNGAD (x=S; ~15-kDa)
4: 258TGNGERTADTSKGQE (~8-kDa)
5: 196VSETxPPGEGEINGNEETG (x=T)
6: 232NSDGSPSGNGAD (~19-kDa)
1 2 3 4 5 6D
36
16
6
250
98
50
16
6
22
36
148
64
3b3aA
AA
Asx
Thr
Ser
Glx
Pro
Gly
Ala
Val
Ile
Leu
Lys
Arg
4
-
2
-
1
3
1
-
-
1#
1
-
-
2#
4
-
2
-
1
3
1
-
-
1
-
-
3#
4
-
2
-
1
3
1
-
-
-
-
-
4#
2
3
1
3
-
3
1
-
-
-
1
1
5#
2
3
1
5
2
4
-
1
1
-
-
-
6#
4
-
2
-
1
3
1
-
-
-
-
-
31.7
-
19.5
-
8.6
22.6
8.6
-
-
1%
7.9
-
-
2%
31.2
-
19.5
-
8.3
23.6
7.8
-
-
9.1
-
-
3%
31.7
-
19.5
-
8.6
22.6
8.6
-
-
-
-
-
4%
12.7
18.6
7.6
19.3
-
21.5
6.2
-
-
-
6.4
6.6
5%
10.0
15.8
5.3
27.1
11.2
20.3
-
4.8
5.0
-
-
-
6%
31.0
2.2
19.1
1.3
10.4
26.7
9.3
-
-
-
-
-
E F
Figure 2 Characterization of small, highly glycosylated Dsp peptides. A: 4-20% Tris/glycine gel stained with stains-all showing fraction
ANS1/2R3-a and -b before (-) and after (+) digestion with chondroitinase ABC. The stains-all positive proteoglycan smears coalesced into a
group of protein bands having apparent molecular weights ranging from 8 to 20-kDa. B: 4-20% Tris/glycine gel stained with stains-all showing
fraction ANS1/2R3-a and -b without (-) and with (+) the reducing agent b-mercaptoethanol. The mobilities of the bands did not change
indicating the absence of disulfide bridges. C: 4-20% Tris/glycine gel stained with stains-all showing the bands from ANS1/2R3-a (3a) and ANS1/
2R3-b (3b) following chondroitinase ABC digestion that were excised from the gel and characterized by amino acid analysis and N-terminal
sequencing. D: 18% Tris/glycine gel stained with stains-all showing the bands following electroelution. E: Results of amino acid analyses showing
the percentage (%) of each amino acid in the 6 peptides and the deduced numbers (#) of each amino acid. The percentages were converted
into number of amino acids by dividing all of the percentages by the lowest meaningful percentage, which corresponded to the percentage of
a single amino acid. F: The complete sequences of each peptide. The Edman sequences are underlined with blank cycles indicated by an “x”.
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peaks by RP-HPLC (Figure 5B). N-terminal sequencing
of these peptides gave blank cycles for Asn77, Asn155,
Thr200, Thr216, and Ser250.
Characterization of Dsp N-linked glycosylation sites
Previously we showed by Western blot analyses that low
molecular weight (LMW) peptides from the N-terminal
region of Dsp can be found in the acid or “A” extract
[42]. To identify glycosylated amino acids in these
peptides, the A extract was fractionated by size exclu-
sion chromatography followed by RP-HPLC (Additional
file 4). The LMW Dsp components in fraction AS2R-g
(Figure 6A) were digested with endoproteinase Glu-C
(V8 endoproteinase) and the digest was fractionated by
RP-HPLC (Figure 6B). Fifteen peaks were observed and
each of these fractions was digested with glycopeptidase
A. Following the N-deglycosylation, each sample was
rechromatographed on the same C-18 column to
demonstrate that deglycosylation of the glycopeptide
had altered its retention time. A shift in retention time
on the column following deglycosylation was accepted
as evidence that the original peptide was glycosylated.
Fractions corresponding to the main chromatographic
peaks that were not present before the glycopeptidase A
digestion (AS2R-g peaks 2, 3, 6, 8, 10, 11 and 12) were
characterized by LC/MSMS analysis (Figure 6C). Five
N-glycosylation sites were identified: Asn37 (NDT; peaks
6, 8, 10, 11, 12), Asn77 (NSS; peaks 6, 8), Asn136 (NGS;
peaks 2 and 3), Asn155 (NAS; peak 6), Asn161 (NAT;
peaks 6, 8), and Asn176 (NNS; peak 2).
Analysis of Sialic Acid in Dsp
It was known early on that Dsp glycosylations are rich
in sialic acid, which was the basis for its designation as
dentin sialoprotein [34]. Sialic acid refers to N-acetyl-
neuraminic acid (Neu5Ac) and its derivatives. To deter-
mine the amount of N-glycosylations in each Dspp
fraction, we released the N-glycosylation with glycopep-
tidase A and chemically attached a fluorescent label.
One fluorescent label was added per N-glycosylation.
Figure 3 Characterization of ANS1/2-R3 pronase digestion products with altered retention times following chondroitinase ABC
digestion. RP-HPLC chromatograms (Abs230 v. min) ANS1/2R3Pr1-d, -h, -i, -j, and -p following chondroitinase ABC digestion. Arrows indicate
retention times of the main peak prior to chondroitinase ABC digestion. N-terminal sequences determined for the contents of each labeled peak
(D, H, I, J1, J2, P1 and P2) are shown on the lower right. Blank cycles, indicated by an “x”, identified Ser238 and Ser250 as modified residues.
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D1 (Ser250)
Figure 4 Characterization of disaccharides attached at Ser238
and Ser250. Supelcosil LC-NH2 chromatograms (Abs
232 v. min) of
GAG products released from ANS1/2R3-Prp (Ser238) and ANS1/2R3-
Prd (Ser250) by chondroitinase ABC digestion compared to GAG
standards (ΔDi-0S; ΔDi-6S; ΔDi-4S; ΔDi-diSD; ΔDi-diSE; ΔDi-triS). Based
upon their retention times, the GAG attachments are observed to
contain chondroitin 6-sulfate (ΔDi-6S) and chondroitin 4-sulfate (ΔDi-
4S). Integration of the areas under the peaks show the ratio of C6 S
to C4 S is 7 to 3.
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The amount of N-glycosylation in each Dsp fraction was
determined by running an aliquot of labeled glycosyla-
tion over an SE-HPLC column and then comparing the
areas under the chromatographic peaks to that of a
commercial A2 glycan standard of known amount and
fluorescence (Additional file 5). To quantify the average
number of sialic acid attachments per N-glycosylation,
we digested LMW-Dsp (containing N-terminal frag-
ments of Dsp) and R5-Dsp (containing Dspp minus the
Dpp domain) fractions with sialidase. The released sialic
acid was digested with aldolase and the product (pyru-
vate) and lactic dehydrogenase were used to oxidize
b-NADH to b-NAD, which was measured spectrophoto-
metrically. The same series of reactions were conducted
on a commercial standard (bovine fetuin). The results
showed that there were, on average, 1.3 sialic acids per
N-glycosylation in the N-terminal region of Dsp, and
about 0.8 molecules of sialic acid, on average, per N-gly-
cosylation in Dspp (Additional file 5).
To identify which forms of sialic acid were present on
the N-linked glycosylations, N-glycosylations were
released from the various Dsp fractions (LMW-Dsp, R3-
Dsp, R4-Dsp, R5-Dsp), given a fluorescent label, and
purified by size exclusion chromatography. Sialic acid
was released from these glycosylations by sialidase diges-
tion, labeled, and then passed through a RP-HPLC col-
umn. By comparing the retention times of the labeled
sialic acid from the Dsp fractions to a similarly-labeled
sialic acid reference panel it was demonstrated that all
of the sialic acid attached to Dsp N-glycosylations are
N-acetylneuraminic acid (Neu5Ac or NANA), which is
the predominant form of sialic acid in mammalian cells
(Additional file 5).
Discussion
In this study we identified six N-linked and three tenta-
tive O-linked glycosylation and the two GAG attach-
ment sites on porcine Dsp (Figure 7). The two GAG
attachment sites are particularly interesting. Xylosyl-
transferase I (XYLT1; 16p13.1) and xylosyltransferase II
(XYLT2; 17q21.3) catalyze the initial step in glycosami-
noglycan biosynthesis and determine if a site will have a
GAG attachment [49]. Experimentally determined GAG
A
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Figure 5 Characterization of glycosylated pronase digestion products of ANS1/2-R4. A: Size exclusion chromatogram (Abs220 v. min) of
ANS1/2-R4 digested with pronase (top); tubes showing results of phenol sulfuric acid assay performed on each size exclusion fraction (bottom; B
is “blank” for negative control). B: RP-HPLC chromatogram (Abs220 v. min) of digestion products in ANS1/2R4-Pr1 showing the 8 fractions (a-h)
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Figure 6 Characterization of glycosylated endoproteinase Glu-
C digestion products of LMW Dsp. A: Contents of fraction AS2R-g
characterized by SDS-PAGE stained with CBB (1), stained with stains-all
(2); by Western blotting using the Dsp antibody (3) or Dgp antibody
(4). B: RP-HPLC chromatogram (Abs220 v. min) of endoproteinase Glu-C
digestion products of AS2R-g. C: Table showing the results of mass
spectrometric (LC/MSMS) analyses of RP-HPLC fractions following
glycopeptidase digestion. Asparagines (N) in the appropriate context
for N-glycosylation that were also found to be 1 Da smaller than
expected (due to deamidation) are indicated in bold and listed as the
posttranslational modification (PTM) site on the right.
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attachment sites identify the range of amino acid con-
texts that are recognized by these enzymes and provide
the data needed to improve the prediction algorythms
for GAG attachment sites.
The two GAG attachment sites are in the most highly
conserved area of Dsp (Additional file 6). The context
for the second site (Ser250; DEEEDKGSGDDEGEE) con-
tains a GSG-motif combined with a high number of sur-
rounding acidic amino acids, so this sequence would be
predicted to be a good acceptor for a xylosylation reac-
tion and result in a high degree of xylosylation catalyzed
by both XT-isoforms [50].
The first site (Ser238, DNSDGSPSGNGADEEED) has
two acidic amino acids on the N-terminal side and a
series of acidic amino acids starting at positions +5 or
+6, which are positive features. However, the proline in
the -1 position is thought to have an inhibitory effect on
the glycosylation reaction [51]. Despite this, our results
indicate that Ser238 is a GAG attachment site. Perhaps
the high conservation of the surrounding amino acids
helps ensure its recognition as a target for glycosylation.
Recently, it was shown that altering the potential GAG
attachment sites sequences in rat Dsp diminished the
apparent size of the recombinant protein on Western
blots, indicating that both of the GAG attachments sites
identified in this study have GAG attachments in rat
Dsp [46].
It is clear from our analyses that the repeating disac-
charide units attached to Ser238 and Ser250 are chondroi-
tin 6-sulfate and chondroitin 4-sulfate, with C6 S
predominating. Based upon antibody analyses, we pre-
viously detected only C6 S attached to porcine Dsp [36].
Dentin matrix protein 1 (Dmp1) is a bone and dentin
proteoglycan that plays a role in phosphate homeostasis
[52]. In rat, the predominant disaccharide unit on Dsp
and Dmp1 is C4 S [53,54].
The role of Dsp GAG chains in dentin formation is
largely unexplored. Proteoglycans such as decorin are
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Figure 7 Porcine Dsp posttranslational modification sites. A: Diagram showing the three regions (Dsp, Dgp, and Dpp) of porcine Dspp.
B: Diagram showing N and O-linked glycosylation sites identified in this study. Among the eight asparagines in the appropriate context for
glycosylation, six were determined to be glycosylated (Asn37, Asn77, Asn136, Asn155, Asn161, Asn176). The glycosylation status Asn67 was not
determined. Asn315 was shown to not be glycosylated, possibly due to an O-glycosylation of Thr316. In porcine Dsp, it was shown that the N-
glycosylations contain, on average, one sialic acid, in the form of N-acetylneuraminic acid, per N-glycosylation. Ser238 and Ser250 were determined
to be GAG attachment sites, with the GAG attachments being comprised of chondroitin 6-sulfate and chondroitin 4-sulfate in a ratio of 7 to 3.
O-glycosylations were suggested by blank cycles at Thr200, Thr216, and Thr316 in samples that were positive for glycosylation by the phenol
sulfuric acid assay and eluted early from a size-exclusion column, but no direct evidence for O-glycosylation was obtained and the conclusion
that these residues are glycosylated should be considered tentative.
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known to regulate collagen fibrillogenesis [55,56]. GAGs
are thought to interact directly with dentin collagen
fibrils, as an electrondense substance that can be
removed from dentin collagen fibrils by chondroitinase
treatment [57]. Dsp is the most abundant proteoglycan
in dentin and is therefore likely to interact with col-
lagen. Chondroitinase activity in the dentin matrix
might regulate interactions between the Dsp GAG
chains and collagen.
Besides having two GAG attachments, porcine Dsp has
at least six N-glycosylations. All of these sites are on the
N-terminal side of the lone cysteine (Cys190) that cova-
lently links two Dsp proteins into a dimer. Although a
high degree of N-glycosylation is a characteristic feature
of Dsp, the individual glycosylation sites are not well con-
served. The N-linked glycosylations on porcine Dsp aver-
age about one sialic acid per N-glycosylation. Previously
it was shown that rat Dsp contained 29.6% carbohydrate
including about 9% sialic acid [34]. Sialic acid attach-
ments can serve a wide range of functions [58]. Sialic
acid moities can be ligands for other molecules, such as
lectins. Perhaps Dsp could form a bridge between mole-
cules that interact with sialic acid and others that interact
with O-glycosylations or GAG attachments.
The two O-glycosylations and two GAG attachments
are all on the C-terminal side of Cys190. Ser238, Ser250,
and Thr216 are perfectly conserved, whereas Thr316 is
conserved in all known Dsp sequences except the
mouse. Thus the O-glycosylations and glycosaminogly-
can attachments are structural elements that are likely
to be essential for Dsp function. Three predicted Golgi
casein kinase phosphorylation sites (Ser294, Ser296 and
Ser319) are all found in the C-terminal side of Dsp and
are perfectly conserved.
The map of porcine Dsp posttranslational modifica-
tions suggests that Dsp is divided into two domains that
are separated by the lone cysteine (Cys190) that cova-
lently links two Dsp proteins. The N-terminal side is
rich in sialidated N-glycosylations; the C-terminal side
contains the GAGs, O-glycosylations, and phosphory-
lated serines.
The Dsp domain of Dspp is not highly phosphorylated
(only 3 predicted sites). In contrast, the small Dgp
domain has four perfectly conserved sites, while Dpp
has well over a hundred. The Dsp domain is not highly
conserved. Only 73 of 377 (19%) if its amino acids are
perfectly conserved among the seven mammalian Dsp
sequences in GenBank, whereas 28/81 (35%) of Dgp is
perfectly conserved. The most highly conserved regions
of Dsp and Dgp are in areas of posttranslational modifi-
cations, highlighting their importance for function. Dsp
is important for the onset of dentin mineralization, and
future studies will investigate the importance PTMs in
carrying out these functions.
Conclusions
Dentin sialoprotein (Dsp), the N-terminal domain of den-
tin sialophosphoprotein (Dspp) was isolated from devel-
oping porcine molars and its posttranslational
modification were characterized. Porcine Dsp has at least
6 N-linked glycosylations (Asn37, Asn77, Asn136, Asn155,
Asn161, and Asn176) that average one sialic acid each, all
in the form of N-acetylneuraminic acid. Porcine Dsp has
exactly two glycosaminoglycan attachments (Ser238 and
Ser250) that are comprised of chondroitin 6-sulfate and
chondroitin 4-sulfate in a ratio of 7 to 3. Three O-linked
glycosylations in Dsp were tentatively assigned (Thr200,
Thr216, and Thr316). Glycosylations divide porcine Dsp
into a heavily N-glycosylated, sialidated N-terminal
domain and a C-terminal domain with two GAG attach-
ments, three O-glycosylations, and three potential phos-
phoserines. The two Dsp domains are separated by the
lone cysteine (Cys190) that connects two Dsp chains into
a covalent dimer. Knowledge of Dsp structure is an
important starting point to understanding the how Dsp
serves to initiate mineralization of dentin.
Methods
All experimental procedures involving the use of ani-
mals were reviewed and approved by the Institutional
Animal Care and Use Program at the University of
Michigan.
Extraction of proteins from dentin powder
Maxillary and mandibular second molar tooth germs
were extracted from 6 month old pigs and the soft tissue
discarded. Enamel was removed by scraping with a cur-
ette and the remaining hard tissue was ground to a pow-
der. All extraction steps were carried out at 4°C or on ice.
The Protease Inhibitor Cocktail Set III (1 mM AEBSF, 0.8
μM aprotinin, 50 μM bestatin, 15 μM E-64, 20 μM leu-
peptin, and 10 μM pepstatin) (Calbiochem, San Diego,
CA) and 1 mM 1,10-phenanthroline (Sigma-Aldrich, St.
Louis, MO) were added into the buffer during the extrac-
tion. The extraction scheme is outlined in Figure 1. Forty
grams of dentin powder (the amount obtained from 32
molars) was homogenized at 4°C in 50 mM Tris-HCl/4
M guanidine buffer (pH 7.4) containing protease inhibi-
tors. Insoluble material was pelleted by centrifugation
and the supernatant was designated the first guanidine
(G1) extract. The guanidine pellet was dialyzed against 4
L of 0.5 M acetic acid containing protease inhibitors until
the tooth mineral has fully dissolved. The dialysis bag
contents were centrifuged, and the supernatant was
designated the acid (A) extract. The pellet was extracted
with 0.5 M acetic acid/2 M NaCl and the supernatant
was designated the acid salt (AN) extract. The AN pellet
was extracted with 50 mM Tris-HCl/2 M NaCl buffer
(pH 7.4) and the supernatant designated the Tris salt
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(TN) extract. The TN pellet was extracted with 50 mM
Tris-HCl/4 M guanidine buffer (pH 7.4). Residual insolu-
ble material (RIM) was pelleted by centrifugation. The
guanidine supernatant was dialyzed against water. Fol-
lowing centrifugation, the pelleted material that had pre-
cipitated during dialysis was designated the second
guanidine pellet (G2P), while the supernatant was desig-
nated the second guanidine extract (G2).
Purification of Dspp-derived proteins
Western blot analyses using a polyclonal antibody raised
against recombinant porcine Dsp [36] showed that low
molecular weight (LMW) Dsp components were in the
A extract, while high molecular weight (HMW) Dsp
components were in the AN extract (Additional file 1).
The AN and A extracts were fractionated by size exclu-
sion chromatography and the fraction containing Dsp
positive material (based upon Western blot analyses)
was further fractionated by reversed phase-high perfor-
mance liquid chromatography (RP-HPLC). For the AN
extract, the HMW Dsp components were found in the
first two chromatographic peaks (AN-S1 and AN-S2),
which were combined and resolved into five fractions by
RP-HPLC [42]. The last three fractions to elute, desig-
nated ANS1/2-R3, ANS1/2-R4, and ANS1/2-R5, were
comprised of successively larger stains-all positive
smears of Dsp proteoglycan, respectively (Additional file
2). The LMW Dsp components in the A extract were
found in the second (S2) of three fractions produced by
size exclusion chromatography. S2 resolved into 14 frac-
tions (designated a through n) on a POROS R2 column
(4.6 mmID × 10 cm), equilibrated with 0.05% TFA and
eluted with a linear acetonitrile gradient containing
0.05% TFA at a flow rate of 1.0 mL/min at room tem-
perature. The LMW Dsp components were identified in
fraction g (AS2R-g; Additional file 4).
To identify glycosylated peptides in porcine Dsp, the
LMW and HMW Dsp components were digested with
endoproteinase Glu-C or pronase and the glycopeptide
products characterized. Endoproteinase Glu-C (Staphy-
lococcus aureus Protease V8) is a serine proteinase that
selectively cleaves peptide bonds C-terminal to acidic
residues with a strong preference for glutamic over
aspartic acid residues [59]. Pronase is a cocktail of pro-
teolytic enzymes that degrades all but short glycopep-
tides that are protected from cleavage by bulky
carbohydrate chains.
Chondroitinase ABC digestion and characterization
ANS1/2-R3
Fraction ANS1/2-R3, which produced a stains-all positive
smear on sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE), was resolved into two parts
(ANS1/S2-R3a and ANS1/S2-R3b) by RP-HPLC
rechromatography (Additional file 2), lyophilized, and
200 μg of each part was resuspended in 40 mM Tris-
HCl/40 mM sodium acetate buffer (pH 8.0) and incu-
bated with 0.2 units of chondroitinase ABC protease free
(Associate of Cape Cod Inc., East Falmouth, MA) at 37°C
for 35 h. The digests resolved into six stains-all positive
bands on SDS-PAGE, which were excised from the gel.
Each gel slice was transferred to a DTube Dialyzer (midi
size) (Novagen/EMD Chemicals, Inc., Gibbstown, NJ)
and the protein electroeluted with 25 mM Tris/250 mM
Tricine/0.025% SDS buffer (pH 8.5) at 150 volts for 3 h.
Each eluate was precipitated with 20% trichloroacetic
acid, incubated in acetone overnight at -80°C and centri-
fuged at 4°C for 30 min at 14,000 × g. The supernatant
was decanted, the pellet was dried under a hood, and was
later characterized by Edman sequencing.
Characterization of ANS1/2-R3 following pronase
digestion
Purified ANS1/2-R3 (33 mg) in 50 mM Tris-HCl buffer
(pH 8.0) was incubated with 0.2 mg of pronase at 37°C for
20 h. The digestion products were fractionated by size
exclusion chromatography using a Sephadex G-15 column
(1.6 cm × 60 cm). The first eluted fraction of the pronase
digest was positive for oligosaccharide or glycosaminogly-
can chains using the phenol-sulphuric acid (PS) assay
(Additional file 3) and was fractionated by RP-HPLC using
a Discovery C18 column (10 mmID × 25 cm) equilibrated
with 0.05% TFA and eluted with a linear acetonitrile gradi-
ent containing 0.05% TFA at a flow rate of 1.0 mL/min at
room temperature. For the PS assay, aliquots from each
Sephadex G-15 or Discovery C18 fraction were evaporated
and 0.3 mL of water, 0.3 mL of 5% phenol, and 1.5 mL of
concentrated sulfuric acid were added. Measuring the
absorbance at 490 nm on a spectrophotometer identified
the peak containing oligosaccharides.
Eight RP-HPLC fractions (Pr1-d, -e, -h, -i, -j, -k, -l and
-p) that were positive for the PS assay (Additional file 3)
were digested with chondroitinase ABC as described
above. At the end of the incubation period, three volumes
of ice-cold ethanol were added to the reaction mixture,
which was then centrifuged for 10 min at 10,000 × g.
Both supernatant and pellet were lyophilized and stored
at -80°C. The lyophilized supernatant was dissolved in
0.6 mL of water and half of the sample was used for the
PS assay. The rest of the sample was used for characteri-
zation of chondroitin sulfate chains. Two PS negative
samples (Pr-1k and l) and five PS positive samples (Pr1-
d, -h, -i, -j and -p) were rechromatographed by RP-HPLC
and characterized by Edman sequencing.
Characterization of LMW Dsp in the A extract
The AS2R-g (0.5 mg) fraction containing LMW Dsp
(Additional file 4) was dissolved with 1 mL of 0.1 M
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ammonium bicarbonate/1 mM EDTA-2Na buffer (pH
7.8). Samples were digested by endoproteinase Glu-C
(Roche Diagnostics, Indianapolis, IN) using an enzyme/
substrate ratio of 1/25 (w/w) at 35°C for 24 h. The digests
were applied onto a Discovery C-18 (10 mm × 25 cm) col-
umn and run at a flow rate of 1.0 mL/min and monitored
at 220 nm (Buffer A: 0.05% TFA; Buffer B: 80% acetoni-
trile/buffer A). Fifteen fractions were collected, lyophilized,
and rechromatographed over the same column.
The 15 purified Glu-C digestion products (approxi-
mately 50-100 μg each) in 0.1 M citrate-phosphate buffer
(pH 5.0) were incubated with 0.2 mU of glycopeptidase A
(Associate of Cape Cod, East Falmouth, MA, USA) con-
taining the Protease Inhibitor Cocktail Set II (0.08 mM of
AEBSF, 6.8 μM of Bestatin, 0.8 μM of E-64, 0.35 mM of
EDTA and 8 μM of Pepstatin A; Calbiochem, San Diego,
CA, USA) at 37°C for 48 h. Three volumes of ice-cold
ethanol were added, then the reaction mixture was centri-
fuged for 10 min at 10,000 × g. Glycopeptides among the
Glu-C digestion products were identified by rechromato-
graphy using the same Discovery C-18 (10 mm × 25 cm)
column. Seven glycopeptides that showed a shift in their
retention times following the glycopeptidase A digestion
were characterized by LC/MSMS analysis (Nextgen
Sciences, Ann Arbor, MI).
Qualitative and quantitative analyses of sialic acid in
Dspp-derived proteins
N-glycosylations were enzymatically released from pur-
ified Dpp (ANS1/2-R2) (190 μg), Dsp (ANS1/2R3-R5)
(170-250 μg), Dgp (AS2Rd-Rf) (160 μg), and LMW
Dsp (AS2R-g) (180 μg) with 1 mU of glycopeptidase A.
The porcine 32-kDa enamelin (90 μg) was also
digested as a positive control. Three volumes of ice-
cold ethanol were added to precipitate the deglycosy-
lated proteins, which were separated from the released
N-glycosylations by centrifugation for 10 min at 10,000
× g. N-glycosylations in the supernatants were evapo-
rated and labeled with 2-aminobenzoic acid (2-AA)
using 2-AA labeling kit and S Cartridge (QA-bio, Palm
Desert, CA). A labeled N-glycan standard (10 pmol;
A2 glycan; QA-bio) and the 2-AA-glycosylations were
separated by size exclusion-HPLC (SE-HPLC) using a
Nanofilm-SEC 150 (7.8 mm × 30 cm) (Sepax Technol-
ogies Inc., Newark, DE) column equilibrated with PBS
and was eluted with the same solution at a flow rate of
1.0 mL/min at the room temperature. The effluent was
continuously monitored by a fluorescence monitor
(FP-2020, JASCO, Tokyo, Japan) using an excitation
wavelength of 320 nm and an emission wavelength of
420 nm (Additional file 5). The amount of released
labeled glycosylations was determined by comparing
the area under its chromatographic peak with the
labeled A2 glycan standard.
For the qualitative analysis of sialic acid, each of the
purified 2-AA glycosylation samples in 50 mM sodium
phosphate buffer (pH 6.0) was incubated with 10 mU of
sialidase Au (QA-bio) for 1 h at 37°C. An aliquot of the
released sialic acid was labeled with 1,2-diamino-4,5-
methylenedioxy-benzene (DMB) using a sialic acid label-
ing kit (QA-bio). The DMB-sialic acid samples were
separated by RP-HPLC using a GlycoSep R (2.1 mm ×
15 cm) (ProZyme Inc., Hayward, CA) column equili-
brated with a mixture of acetonitrile-methanol-water
(9:7:84, v/v) and eluted with the same solution at a flow
rate of 1.0 mL/min at the room temperature. A fluores-
cence monitor using an excitation wavelength of 373
nm and an emission wavelength of 448 nm continuously
monitored the effluent. The form of sialic acid in each
sample was identified by comparing with retention
times of a DMB-labeled sialic acid reference panel (QA-
bio) (Additional file 5).
For the quantitative analysis of sialic acid we used the
SialiQuant sialic acid quantitation kit (QA-bio). LMW Dsp
(AS2R-g), HMW Dsp (ANS1/2-R5), and bovine fetuin
(33.6 nmol) were digested with sialidase AU. These reac-
tions, as well as 10 nmol of N-acetylneuraminic acid, were
digested with N-acetylneuraminic acid aldolase in Tris
reaction buffer at 37°C for 30 min. A solution of b-NADH
was added and the initial b-NADH absorbance was read at
340 nm (A340 initial). The reaction mixture was incubated
with lactic dehydrogenase for 1 h at 37°C, then the final
b-NADH absorbance was read (A340 final) and the nmoles
of sialic acid calculated: nmoles of sialic acid = (A340 initial
- A340 final) × 1000/6.22 (mM extinction coefficient of
b-NADH is 6.22 at 340 nm) (Additional file 5). The result
for the 10 nmol of N-acetylneuraminic acid was 8.68
nmol, so the results of other samples were corrected by
multiplying by 1.15. For the bovine fetuin control this cor-
rection gave a result of 32.42 nmol.
SDS-PAGE and Western blotting
SDS-PAGE was performed using Novex 4-20% Tris-Gly-
cine Gel (Invitrogen, Carlsbad, CA, USA). Samples were
dissolved in Laemmli sample buffer (Bio-Rad) and elec-
trophoresis was carried out using a current of 30 mA
for about 1 h. The gels were stained with Simply Blue
Safe Stain (Invitrogen) or Stains-all (Sigma, St. Louis,
MO, USA). The apparent molecular weights of protein
bands were estimated by comparison with SeeBlue®
Plus2 Pre-Stained Standard (Invitrogen). Proteins were
electrotransferred from SDS-PAGE onto a Hybond-ECL
nitrocellulose membrane (GE Healthcare Bio-Sciences
Corp.). Porcine Dsp and mouse chondroitin 6-sulfate
(ΔCh-6S) antibodies were used at dilution of 1:50,000.
The membrane was immunostained by chemilumines-
cent detection with ECL Advance Western Blotting
Detection Kit (GE Healthcare Bio-Sciences Corp.).
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Amino Acid Analysis
The purified Dsp samples (ANS1/2-R3 to R5) (20-30 μg)
were hydrolyzed with 6 N HCl at 115°C for 16 h. The
amino acid analyses were performed using a Hitachi L-
8900PH instrument at the W. M. Keck Biotechnology
Resource Lab at Yale University.
Automated Edman Degradation
Automated Edman degradation used the 494HT ABI
Edman Protein Sequencer at the W.M. Keck Biotechnol-
ogy Resource Lab at Yale University.
Additional material
Additional file 1: Characterization of porcine dentin powder
extracts by SDS-PAGE and Western blotting. This file shows a CBB
and a stains-all SDS-PAGE, and a Western blot using a Dsp polyclonal
antibody of porcine dentin power extracts and fractions.
Additional file 2: Purification of high molecular weight (HMW)
pieces of Dspp that contained Dsp. This file shows RP-HPLC
chromatograms that yielded the ANS1/2-R1 through ANS1/2-R5 fractions
and shows these fractions characterized by CBB and stains-all stained
SDS-PAGE and Western blotting using a Dsp polyclonal antibody and a
Dgp anti-peptide antibody.
Additional file 3: Isolation of glycosylated peptides from the
pronase digestion of ANS1/2-R3. This file shows the size exclusion
chromatogram of the A extract and characterization of its three major
fractions by CBB and stains-all stained SDS-PAGE, and by Western
blotting using Dsp polyclonal antibody. It also shows the RP-HPLC
chromatogram for separation of the second size exclusion fraction and
characterization of the resulting 14 fractions by CBB and stains-all stained
SDS-PAGE, and by Western blotting using a Dsp polyclonal antibody.
Additional file 4: Isolation of low molecular weight (LMW) Dsp
components in the A extract. This file shows the size exclusion
chromatogram of pronase-digested ANS1/2-R3 reacted with phenol-
sulfate (to detect glycosylations); the RP-HPLC chromatogram that
fractionated the potentially glycosylated pronase digestion products into
26 parts; and the results of a spectrophotometric analysis that identified
the 8 fractions containing glycosylated peptides.
Additional file 5: Characterization of sialic acid in Dsp N-
glycosylations. This file shows the fluorescent chromatograms from size
exclusion-HPLC separations of N-glycosylations that were previously
released from various Dsp fractions by glycopeptidase A digestion and
then labeled with 2-AA to determine the quantity of their labeled
glycosylations by comparing the areas of their chromatographic peaks to
those generated by known quantities of a 2-AA labeled standard.
Fluorescent chromatograms from the RP-HPLC separations of sialic acid
released from the N-glycosylations by sialidase digestion and labeled
with DMB are shown that, by comparison to sialic acid standards,
allowed the determination of the form of sialic acid on Dsp
glycosylations (N-acetylneuraminic acid).
Additional file 6: Alignment of Dsp amino acid sequences from
GenBank. This file shows the amino acid alignment of Dsp from pig,
panda, dog, monkey, human, mouse and rat, highlighting the
conservation of modified sequences.
List of Abbreviations Used
A: Acid extract; AN: acid-salt extract; Bmp: bone morphogenetic protein; A2
glycan: disialo-galactosylated biantennary oligosaccharide; ΔDi-0S: 2-
acetamido-2-deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-D-
galactose; ΔDi-4S: 2-acetamido-2-deoxy-3-O-(beta-D-gluco-4-
enepyranosyluronic acid)-4-O-sulfo-D-galactose; ΔDi-6S: 2-acetamido-2-
deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-6-O-sulfo-D-galactose;
ΔDi-diSD: 2-acetamide-2-deoxy-3-O-(2-O-sulfo-b-D-gluco-4-
enepyranosyluronic acid)-6-O-sulfo-D-galactose; ΔDi-diSE: 2-acetamide-2-
deoxy-3-O-(b-D-gluco-4-enepyranosyluronic acid)-4,6-bis-O-sulfo-D-galactose;
ΔDi-triS: 2-acetamido-2-deoxy-3-O-(2-O-sulfo-b-d-gluco-4-enepyranosyluronic
acid)-4,6-di-O-sulfo-d-galactose; DD: dentin dysplasia; DGI: dentinogenesis
imperfecta; Dgp: dentin glycoprotein; DMB: 1,2-diamino-4,5-
methyleneoxybenzene; Dmp1: dentin matrix protein 1; Dsp: dentin
sialoprotein; Dspp: dentin sialophosphoprotein; G1: first guanidine extract;
G2P: second guanidine pellet; G2: second guanidine extract. GAG:
glycosaminoglycan; LMW: low molecular weight; HMW: high molecular
weight; HPLC: high performance liquid chromatography; Mmp: matrix
metalloproteinase; β-NADH: beta-nicotinamide adenine dinucleotide. NP-
HPLC: normal phase-high performance liquid chromatography; Pr: pronase
size exclusion fraction; PS: phenol-sulphuric acid; RIM: Residual insoluble
material; R: RP-HPLC fraction; RP-HPLC: reversed phase-high performance
liquid chromatography; S: size exclusion fraction; SDS-PAGE: sodium dodecyl
sulfate-polyacrylamide gel electrophoresis; SCPP: secretory calcium-binding
phosphoprotein; SE-HPLC: size exclusion-high performance liquid
chromatography; SIBLINGs: small integrin-binding ligand, N-linked
glycoproteins; TN: tris-salt extract; 2-AA: 2-aminobenzoic acid.
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